| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 215.79 mm | 215.79 mm | 215.79 mm | 215.79 mm | 215.79 mm | 215.79 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 21.32 mm | 16.68 mm | 18.71 mm | 10.98 mm |
| Cash used (since last report) | n/a | n/a | 44.35 mm | 34.70 mm | 38.91 mm | 22.84 mm |
| Cash remaining | n/a | n/a | 171.44 mm | 181.09 mm | 176.87 mm | 192.95 mm |
| Runway (months of cash) | n/a | n/a | 8.0 | 10.9 | 9.5 | 17.6 |
| 13F holders | Current |
|---|---|
| Total holders | 168 |
| Opened positions | 39 |
| Closed positions | 9 |
| Increased positions | 55 |
| Reduced positions | 53 |
| 13F shares | Current |
|---|---|
| Total value | 1.57 tn |
| Total shares | 34.81 mm |
| Total puts | 303.90 k |
| Total calls | 907.60 k |
| Total put/call ratio | 0.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Cormorant Global Healthcare Master Fund | 9.50 mm | $10.45 mm |
| Cormorant Asset Management | 1.69 mm | $130.31 bn |
| Vida Ventures | 1.47 mm | $0.00 |
| BlackRock | 1.46 mm | $112.55 bn |
| Perceptive Advisors | 1.33 mm | $102.34 bn |
| T. Rowe Price | 1.21 mm | $93.01 mm |
| Venrock Healthcare Capital Partners III | 1.19 mm | $90.70 mm |
| MS Morgan Stanley | 1.16 mm | $89.55 bn |
| Vanguard | 1.06 mm | $81.86 bn |
| Capital Research Global Investors | 993.57 k | $76.47 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Feb 25 | Alex Nemiroff | Common Stock | Payment of exercise | Dispose F | No | No | 85.4 | 51 | 4.36 k | 20,831.667 |
| 12 Feb 25 | Lauren Mastrocola | Common Stock | Payment of exercise | Dispose F | No | No | 85.4 | 40 | 3.42 k | 10,441.656 |
| 12 Feb 25 | Marcio Souza | Common Stock | Payment of exercise | Dispose F | No | No | 85.4 | 401 | 34.25 k | 53,559 |
| 12 Jan 25 | Timothy Edwin Kelly | Common Stock | Payment of exercise | Dispose F | No | No | 63.15 | 676 | 42.69 k | 24,030 |
| 10 Jan 25 | Marcio Souza | Common Stock | Grant | Acquire A | No | No | 0 | 37,500 | 0.00 | 53,960 |
| 10 Jan 25 | Marcio Souza | Stock Option Common Stock | Grant | Acquire A | No | No | 63.15 | 75,000 | 4.74 mm | 75,000 |
| 10 Jan 25 | Timothy Edwin Kelly | Common Stock | Grant | Acquire A | No | No | 0 | 12,500 | 0.00 | 24,706 |
| 10 Jan 25 | Timothy Edwin Kelly | Stock Option Common Stock | Grant | Acquire A | No | No | 63.15 | 25,000 | 1.58 mm | 25,000 |
